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Molecular Mechanisms of Pluripotency in  
Murine Embryonic Stem Cells 
Elisa A. Casanova, Kurt Bürki and Paolo Cinelli 
Institute of Laboratory Animal Science, University of Zurich 
Switzerland 
1. Introduction 
Embryonic stem cells (ESCs) are pluripotent cells, which can be isolated from the inner cell 
mass (ICM) of blastocyst stage embryos. They are defined by two properties: they can 
indefinitely self-renew in vitro and contribute to the formation of all cells of an adult 
organism, including functional gametes for genome transmission. Due to their pluripotent 
state ESCs can be used for various applications, like the generation of knockout or 
transgenic animals, and potentially as a cell source for cell therapy in regenerative medicine. 
Alternatively self-renewing cells with pluripotent potential can also be generated by 
specifying germ cells with extrinsic factors (Matsui, 1992) or by reprogramming somatic 
cells using gene transfection to generate the so called induced pluripotent stem cells (iPSCs) 
(Takahashi and Yamanaka, 2006). 
Due to the fundamental characteristics of ESCs, developmental biology, regenerative 
medicine and cancer biology are more and more interested in understanding the molecular 
mechanisms controlling stem cells. Even though a lot of efforts have been made in the past 
years to elucidate the factors that regulate stem cell self-renewal and pluripotency, the 
precise mechanism of how these processes are regulated remains largely unknown. In this 
chapter we will give an overview on the known molecular pathways and transcription 
factors involved in maintaining pluripotency, by especially focusing on the core 
transcription factors OCT3/4, SOX2, Nanog, and STAT3. Subsequently we will discuss the 
epigenetics of ESCs and iPSCs and finally conclude this chapter with remarks and 
discussions. 
1.1 Establishing and maintaining ESCs in vitro 
ESC lines are derived from the preimplantation embryo, precisely from the ICM of the 
blastocysts. Although the presence of self-renewing, pluripotent, cells is transient in vivo, 
apparently immortal cell lines with these properties can be obtained in vitro. Once removed 
from the blastocyst, the cells of the ICM can be cultured under special conditions, into ESCs, 
which maintain an undifferentiated status (Evans and Kaufman, 1981; Martin, 1981). Under 
other conditions, for example by giving the right extrinsic and intrinsic signals, ESCs can 
differentiate into all the cell types that make up the organism. Pluripotent ESCs are 
characterized by the expression of specific cell surface glycoproteins such as the stage-
specific embryonic antigen 1 (SSEA-1) (Solter and Knowles, 1978) as well as by the presence 
of transcription factors such as OCT3/4 (Schöler, 1991; Schöler et al., 1989) and Nanog 
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(Chambers et al., 2003). High expression levels of alkaline phosphatase also characterize 
ESCs. Furthermore, ESCs exhibit a short G1 phase of the cell cycle (Rohwedel et al., 1996) 
and a high telomerase activity (Thomson et al., 1998). Other essential properties of ESCs 
include growth as multicellular colonies, normal and stable karyotypes, and prolonged 
undifferentiated culture.  
Derivation and maintenance of murine ESCs in vitro was originally achieved by using 
mitotically inactivated embryonic fibroblasts (feeders) and/or the cytokine leukaemia 
inhibitory factor (LIF) in combination with fetal calf serum and/or the growth factor bone 
morphogenetic protein (BMP) (Smith et al., 1988; Ying et al., 2003). However, the same 
culture conditions are not sufficient for derivation of ESCs from most of the mouse strains 
and not at all from the rat. The genetic background strongly affects the efficiency of ESC 
isolation and almost all lines in use are derived from the strain 129. Even though ESCs were 
discovered more than 25 years ago only limited number of ESCs of proven ability to 
colonize the germ-line have been obtained and only a few mouse strains other than 129 
(Simpson et al., 1997). Only after adjusting the culture conditions, germ line competent 
inbred ESCs could be established, e.g. from C57BL6/J (Keskintepe et al., 2007; Ledermann 
and Bürki, 1991), DBA/1lacJ (Roach et al., 1995), BALB/c (Kawase et al., 1994; Noben-
Trauth et al., 1996), and CBA mice (Lodge et al., 2005). Recently it has been shown that 
extrinsic stimuli are dispensable for derivation and maintenance of the pluripotent state. 
Culture conditions free from feeders, serum and cytokines were established by using a 
combination of small-chemical molecules, which inhibit the fibroblast growth factor 
(FGF)/mitogen-activated protein kinase (MEK)/extracellular signal-related kinase 
(ERK1/2) and the glycogen synthase kinase 3 (GSK3) (Ying et al., 2008). These culture 
conditions are known as 3i or 2i and have been applied for derivation of ESCs from non-
permissive mouse strains like non-obese diabetic (NOD) mice (Nichols et al., 2009) but also 
from rat embryos, resulting in the production of the first germ-line competent rat ESCs 
(Buehr et al., 2008; Li et al., 2008).  
The finding that by using the 2i conditions it is nowadays possible to derive ESCs from 
almost all the mouse strains and importantly also from the rat is surely of high importance 
in the field of ESC research.  
In the following paragraphs we will review the most important molecular and cellular 
mechanisms that regulate stem cell self-renewal and pluripotency prevalently in mouse 
ESCs, since they are the most investigated ESCs. 
2. Signalling through cytokine receptors: LIF/gp130 pathway  
In 1988 Austin Smith and colleagues isolated a soluble glycoprotein that prevents stem cell 
differentiation and established that ESC self-renewal was dependent on paracrine signals 
produced from the feeders on which ESCs were cultivated (Smith et al., 1988). The principal 
factor required for self-renewal was shown to be leukaemia inhibitory factor (LIF) (Gearing 
et al., 1987; Williams et al., 1988). Lif knockout feeders were reported to be unable to support 
ESCs self-renewal (Stewart et al., 1992), indicating that supply of LIF was a key attribute of 
feeders. LIF belongs to the family of interleukin (IL)-6-type cytokines and exerts its effects 
by binding to a two-part receptor complex, which consists of the low-affinity LIF receptor 
(LIFRβ) and the glycoprotein 130 (gp130). LIF induces heterodimerization of the LIFRβ and 
gp130 resulting predominantly in the activation of the JAK/STAT signal transduction 
pathway, which promotes self-renewal in ESCs. Several studies showed that LIFRβ receptor 
is not sufficient to mediate the signal to maintain ESCs self-renewal, whereas gp130 is (Niwa 
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et al., 1998; Starr et al., 1997). These results indicate that gp130 is the main component of the 
activated LIFRβ/gp130 receptor. As we will see in the following chapters activation of 
LIFRβ/gp130 receptor through the binding of LIF leads also to the activation of the mitogen-
activated protein kinase (MAPK) and the phosphatidylinositol-3 phosphate kinase (PI3K) 
pathways, which together with the JAK/STAT3 pathway are essential for regulating 
biological responses in ESCs.  
In the embryo the epiblast is the transient population of cells from which the foetus is 
derived. Because of their characteristics, ESCs seem to be the in vitro counter part of the 
epiblast cells in vivo. However, in contrast to the LIF dependency of ESCs, early epiblast cells 
do not require LIF stimulation, since Lif -/- embryos develop normally into later stages 
(Stewart et al., 1992) and embryos carrying mutations on the LIFβR and gp130 receptor 
develop normally, at least until mid-gestation (Li et al., 1995; Nakashima et al., 1999; Ware et 
al., 1995). Nevertheless, it has been shown that the embryos do express LIF, LIFβR and the 
gp130 mRNA indicating a possible function of this pathway also in vivo.  
Mice can temporary arrest embryogenesis at the blastocyst stage; this phenomenon is called 
diapause and has evolved in certain mammals to overcome sub-optimal conditions for 
pregnancy. During diapause the embryos develop to the hatched blastocyst stage but then 
stop their development remaining unimplanted in the uterus. This situation can persist in 
mice for weeks, a period during which the epiblast cells have to be maintained pluripotent 
till the development of the embryo is restored. Interestingly ESCs were first established from 
diapause embryos (Evans and Kaufman, 1981). It has been shown that development arrested 
embryos carrying mutation on the LIFβR and the gp130 receptors fail to restore normal 
embryogenesis (Nichols et al., 2001). These findings highlight the absolute requirement for 
LIF/gp130 signalling in the epiblast during diapause and give also an explanation why 
ESCs are LIF dependent. However this is a facultative situation, because the pathway is 
dispensable for early development without diapause.  
2.1 JAK/STAT3 signalling and self-renewal 
Binding of the cytokine LIF to the receptor results in conformational changes in the 
intracellular part of the receptor. Cytosolic tyrosine kinases of the JAK family are then 
recruited to the receptor. The activated receptor phosphorylates the tyrosine residues in the 
kinase molecule that become docking sites for the STAT3 transcription factors. When bound 
to the receptor, STAT3 molecules are phosphorylated on the tyrosine 705 (Tyr705) residues 
and dimerize with another phosphorylated STAT3. The dimers are then translocated to the 
nucleus in a regulated manner where they bind to promoter and enhancer regions of their 
target genes (Fig.1).  
Active STAT3 is necessary and sufficient for maintaining pluripotency in ESCs (Cinelli et al., 
2008; Matsuda et al., 1999; Niwa et al., 1998). Matsuda and colleagues used a chimeric 
STAT3-estrogen receptor (STAT3-ER) composed of the entire coding region of STAT3 and 
the ligand-binding domain of the estrogen receptor. Dimerization of the chimeric STAT3 
was activated after treatment with the estrogen derived 4-hydroxy-tamoxifen (4-OHT). ESCs 
cultivated in presence of 4-OHT were able to self-renew in absence of LIF. In a recent study, 
by using the same STAT3 inducible system we were able to generate with high efficiency 
ESCs from the non-permissive FVB/N mouse strain (Cinelli et al., 2008). Wild type FVB/N 
ESCs derived in presence of LIF were not able to generate chimeras whereas cells derived 
from transgenic ICMs overexpressing STAT3-ER, in absence of LIF and in presence of 4-
OHT, were able to generate germline competent ESCs (Cinelli et al., 2008).  
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The Socs genes (Suppressor of cytokine signalling) are well characterized STAT3 target 
genes, whose encoded proteins generally act in a negative feedback loop to suppress further 
STAT3 signalling (O'Sullivan et al., 2007) (Fig 1.). Although overexpression of STAT3 
promotes stem cell self-renewal and maintenance of pluripotency in the absence of LIF and 
in presence of serum (Cinelli et al., 2008; Matsuda et al., 1999), inactivation of STAT3 in LIF-
maintained ESCs promotes spontaneous differentiation (Niwa et al., 1998). Even though 
these lines of evidence establish STAT3 as an essential component of the LIF-dependent self-
renewal in ESCs, the downstream target genes of activated STAT3 have remained elusive. In 
order to isolate these genes, several studies based on chromatin immunoprecipitation (ChIP) 
analysis or on microarray technology have been performed.  
Recently Cartwright et al. indicated a role for the transcription factor c-MYC in self-renewal 
by functioning as a key target of LIF/STAT3 signalling (Cartwright et al., 2005). Like other 
genes involved in the maintenance of pluripotency, such as Nanog (Chambers et al., 2003), 
Klf2, (Hall et al., 2009), Pem/Rhox5 (Cinelli et al., 2008; Fan et al., 1999) and Pramel7 (Cinelli et 
al., 2008), constitutive expression of c-MYC renders self-renewal independent of LIF 
(Cartwright et al., 2005). On the other hand expression of a dominant negative form of c-
MYC promotes differentiation (Cartwright et al., 2005). c-MYC is a transcription factor that 
controls many different biological processes, such as cell proliferation, growth, 
differentiation and apoptosis. Several studies have shown the importance of this gene in 
embryonic development, since homozygous deletion of c-Myc in the mouse results in 
embryonic lethality before E10.5 of gestation (Davis et al., 1993). Interestingly, 
overexpression or amplification of the c-Myc gene has been detected in numerous solid 
tumours and blood malignancies (Dang et al., 1999). 
Cartwright and colleagues demonstrated by ChIP analysis that the c-Myc gene is a direct 
transcriptional target of the LIF/STAT3 pathway in ESCs and that the sole overexpression of 
c-MYC is sufficient to maintain self-renewal in absence of LIF (Cartwright et al., 2005). Not 
surprisingly, c-MYC is one of the four transcription factors found to be able, together with 
OCT3/4, KLF4, and SOX2, to reprogram somatic cells into undifferentiated, induced 
pluripotent stem cells (iPSCs) (Takahashi and Yamanaka, 2006). 
In a recent microarray study we could identify a group of 26 hypothetical STAT3 target 
genes (Cinelli et al., 2008). In situ hybridization experiments indicated that the expression of 
four of the up-regulated genes was restricted to the ICM of the blastocysts, pointing to their 
potential role in maintaining pluripotency in ESCs. Overexpression in ESCs of two of these 
genes, namely the Pem/Rhox5 homeobox-containing gene and the Pramel7 gene, were shown 
to be sufficient to maintain expression of pluripotency markers in absence of LIF. These 
results suggest that these two genes could represent possible STAT3 transcriptional target 
genes, involved in self-renewal and maintenance of pluripotency in ESCs (Cinelli et al., 
2008). 
The fact that overexpression of the transcription factor Nanog does not increase significantly 
the level of phosphorylated STAT3, and vice versa the overexpression of STAT3 seems not to 
affect Nanog expression leads to the conclusions that Nanog is not a direct transcriptional 
target of STAT3, nor does it regulate STAT3 activity (Chambers et al., 2003). Moreover 
increased STAT3 activity maintains pluripotency even when Nanog expression is reduced 
(Bourillot et al., 2009), confirming that these two transcription factors are regulated through 
different signals. Nevertheless, in a recent study it was shown that 55% of the putative 
STAT3 target genes display binding sites for Nanog, and 41% of the putative Nanog target 
genes display binding sites for STAT3 (Chen et al., 2008). These results suggest that both 
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transcription factors co-regulate the expression of a large number of target genes, whose 
expression is involved in the maintenance of the undifferentiated state in ESCs. Bourillot et 
al. identified in a microarray study twenty-four STAT3 target genes which showed binding 
sites for STAT3 and/or Nanog (Bourillot et al., 2009). Knockdown experiments showed 
increased differentiation in LIF-supportive conditions, confirming that these STAT3 target 
genes contribute to the maintenance of the undifferentiated state (Bourillot et al., 2009). 
Among these there were some already identified as STAT3 targets, like Pim-1 and Pim-3 
kinases (Aksoy et al., 2007) and two genes of the Krüppel-factors family, namely Klf4 and 
Klf5. The Klf genes have been proposed as downstream targets of LIF/STAT3 also by other 
research groups (Hall et al., 2009; Li et al., 2005; Niwa et al., 2009). Recently Hall et al. 
showed that OCT3/4 in addition to the LIF/STAT3 signalling activates the Krüppel-factors 
KLF4 and KLF2 and that their overexpression reduces LIF dependence (Hall et al., 2009). 
However only KLF2 was able to sustain pluripotency in absence of either LIF or Stat3, and 
was shown to be OCT3/4 induced. KLF4 was shown to be selectively induced by 
LIF/STAT3 but was not sufficient in absence of the LIF/STAT3 signalling to sustain 
prolonged ESCs self-renewal. Interestingly, like c-MYC, also KLF4 is one of the four 
transcription factors that are able to reprogram somatic cells into undifferentiated, self-
renewing cells (Takahashi and Yamanaka, 2006). 
In the molecular mechanisms involved in the maintenance of pluripotency in ESCs extrinsic 
stimuli converge with intrinsic circuitries in a synergistic manner propagating the 
undifferentiated and self-renewing state in ESCs. STAT3 is an important regulator of mouse 
ESC self-renewal and it is known to inhibit differentiation into both mesoderm and 
endoderm lineages (Ying et al., 2003) by preventing the activation of lineage-specific 
differentiation programs. However its mechanisms of action remain to be better elucidated.  
2.2 gp130-dependent activation of the MAPK/ERK pathway 
Self-renewal and differentiation converge downstream from the LIFβR/gp130 receptor. The 
binding of the cytokine LIF to the heterodimeric receptor not only activates the JAK/STAT3 
pathway but also the mitogen-activated protein kinase (MAPK) pathway that culminates in 
the activation of the extracellular signal-regulated kinases (ERK1/2). Because it has been 
shown that ERK regulates early differentiation in vivo and in vitro (Kunath et al., 2007; 
Nichols et al., 2009b), the balance between self-renewal and differentiation has to be 
maintained in order to preserve the undifferentiated state of ESCs. 
Active gp130 receptor can also associate with the protein tyrosine phosphatase SHP-2 
(Fukada et al., 1996), which acts as a positive effector of the MAPK signalling cascade. 
Interaction between active gp130 receptor and SHP-2 phosphatase induces the recruitment 
of GAB1. The complex formed by the gp130 receptor, SHP-2 and GAB1 proteins, through 
the activation of further kinases (RAS/RAF and MEK) results in the activation of the ERK1 
and ERK2 kinases (Takahashi-Tezuka et al., 1998) (Fig.1).  
Burdon et al. confirmed that after stimulation with LIF, ERK1 and ERK2 were activated 
through phosphorylation of SHP-2 (Burdon et al., 1999). Surprisingly they also showed that 
suppression of the SHP-2/ERK signalling was not affecting propagation of stem cells, but on 
the contrary it was enhancing ESCs self-renewal (Burdon et al., 1999). This study indicates 
that SHP-2/ERK signalling activation is a necessary component of the normal differentiation 
processes. Differentiation of ESCs into embryoid bodies in vitro was associated with an 
induction of expression of G1 cyclins, a lengthening of the G1 phase and a decrease in the 
rate of cell division (Savatier et al., 1996). As we mentioned before, ESCs typically exhibit a 
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short G1 phase of the cell cycle (Rohwedel et al., 1996) and high rate of cell divisions. 
Entrance into the G1 phase of the cell cycle is a prerogative for cell differentiation. ERK 
signalling is known to regulate proliferation and survival of somatic cells (Lloyd, 1998), and 
in vivo phosphorylated ERK has been detected from the 2-cell stage till the blastocyst stage 
(Wang et al., 2004). Incubation of 2-cell stage embryos with an ERK inhibitor results in a 
developmental arrest at the four-cell stage embryo, however, normal embryo development 
can be restored once the inhibitor is removed (Maekawa et al., 2007). This confirms that the 
ERK1/2 pathway is required for progression of early cell division cycles in the 
preimplantation embryo. In contrast to many mammalian cells, where ERK activity is 
essential for the cell cycle progression from G0/G1 to S phase (Lewis et al., 1998), during the 
development from the 2-cell to the 8-cell stage embryo, ERK signalling seems to be essential 
in the G2/M transition (Maekawa et al., 2007).  
 
 
Fig. 1. gp130/LIF dependent STAT3 and MAPK/ERK signalling 
Interestingly the ERK pathway may be able to inhibit the JAK/STAT3 pathway at the level 
of STAT3. It has been shown that ESCs knockout for Shp2 phosphatase after LIF stimulation 
showed an increased phosphorylation of STAT3 when compared to the wild type cells 
(Chan et al., 2003). These data support the evidence that the two pathways seem to converge 
and thereby determine the choice between self-renewal and differentiation (Fig. 1). 
Recently Ying et al. cultivated ESCs in a serum-free medium containing B27- and N2-
supplement in presence of selective small-chemical inhibitors of the FGF receptor and the 
ERK kinase in combination with a GSK3 inhibitor, the so called 3i or 2i conditions (Ying et 
al., 2008). While the first two inhibitors are involved in selectively blocking differentiation 
signals induced by the ERK pathway, the third inhibitor is used for blocking the negative 
regulation on biosynthetic pathways driven by the GSK3 protein (Ying et al., 2008). This 
work indicates that by inhibiting differentiation-inducing signals from the MAPK pathway 
by 3i/2i it is possible to maintain self-renewal in absence of LIF/STAT3 stimulation. This 
was confirmed by the fact that under these conditions neither STAT3 nor SOCS3 activation 
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was detected. Moreover it was possible to establish Stat3 null cells, which did not show 
morphologically differences when compared with the wild type cells. All the different cell 
lines established under the 3i conditions expressed the typical pluripotency markers like 
OCT3/4 and Nanog and were able to contribute to chimera formation and germ line 
transmission (Ying et al., 2008).  
2.3 gp130-dependent activation of the PI3K signalling  
There are three distinct classes of phosphatidylinositol-3 phosphate kinase (PI3K); members 
of the class IA family of PI3Ks are activated via the LIF/gp130 receptor (Fig. 2.). The 
products of PI3K transmit the signals through downstream effectors including the 
serine/threonine protein kinase B (PKB, also known as AKT). AKT has been implicated in 
many cellular processes like regulation of the cell cycle progression, cell death, adhesion, 
migration, metabolism and tumorigenesis (for review see Brazil et al., 2004). 
Initially it was shown that this pathway was implicated in the control of proliferation in 
ESCs (Jirmanova et al., 2002; Takahashi et al., 2003). Paling et al. demonstrated that LIF 
induced PI3K signal activation in ESCs is involved not only in the regulation of cell 
proliferation but also in their self-renewal (Paling et al., 2004). ESCs incubated with LIF and 
a small chemical PI3K inhibitor showed less alkaline phosphatase activity compared to the 
untreated control cells, indicating a reduced ability of LIF to promote self-renewal. However 
these cells did not show altered levels of phosphorylated STAT3 when compared to the 
control cells. This result led to the conclusion that Stat3 is not a target of PI3K action. The 
loss of self-renewal and the consequently differentiation of the cells after inhibition of PI3K 
was explained by an increase in ERK phosphorylation upon LIF stimulation (Paling et al., 
2004). These findings are consistent with other studies were it was reported PI3K playing a 
role in negatively regulating ERK activity in ESCs (Hallmann et al., 2003). Paling et al. 
demonstrated that self-renewal was restored after incubation with both ERK and PI3K 
inhibitor, therefore confirming that the regulation of ERK activity by PI3K signalling 
contributes to the determination of ESCs self-renewal. 
The involvement of PI3K/AKT signalling in the regulation of stem cell systems has been 
also proposed from studies of conditional Pten-deficient mice. PTEN is a lipid phosphatase 
that antagonizes the physiological and pathological processes of PI3K/AKT pathway (Stiles 
et al., 2004). It was shown for example that self-renewal of neural stem cells was increased in 
brain-specific mutant mice lacking Pten gene (Groszer et al., 2001). It was therefore 
interesting to investigate if a constitutive active form of AKT was able to support self-
renewal in ESCs. Watanabe and colleagues investigated this hypothesis by generating ESCs 
expressing a myristoylated, active form of AKT and they demonstrated that constitutive 
expression of AKT liberates ESCs from LIF-dependence. These cells showed no alteration in 
the level of phosphorylated STAT3 compared to the control cells, but interestingly showed 
an increased ERK phosphorylation (Watanabe et al., 2006). These findings are in contrast 
with the results from Paling et al. that observed an increased ERK phosphorylation upon 
PI3K inhibition thereby attributing to the PI3K signalling an involvement in controlling ERK 
phosphorylation and therefore blocking differentiation.  
GSK3β (glycogen synthase kinase 3β) is a common target from the PI3K/AKT pathway and 
the WNT pathway, which phorphorylation leads to its inactivation (Fig. 4.). WNT blocks 
proteasome-mediated degradation of β-catenin through the inhibition of GSK3β (Moon et 
al., 2004). Watanabe et al. postulated an involvement of the β-catenin signalling in the AKT-
mediated maintenance of the undifferentiated state. Although in the transgenic ESCs 
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expressing a constitutive active form of AKT, GSK3β phosphorylation was enhanced, β-
catenin signalling was not activated (Watanabe et al., 2006). They concluded that AKT-
dependent maintenance of the undifferentiatied state in ESCs was independent from the 
WNT/β-catenin signalling. Long term treatment of ESCs with the PI3K inhibitor LY294002 
was shown to inhibit the proliferation and to induce cell cycle arrest at the G1 phase 
(Jirmanova et al., 2002). It is known that PI3K/AKT controls cell-cycle regulation: AKT 
promotes the G1 to S phase transition by facilitating the formation of cyclin/CDK complexes 
(Brazil et al., 2004). ESCs lack cell-cycle inhibitory mechanisms which are acquired only 
upon differentiation (Burdon et al., 2002). It is therefore possible that AKT-mediated 
maintenance of self-renewal in ESCs is due to its ability to block the cell-cycle inhibitory 
mechanisms and consequently block differentiation (Watanabe et al., 2006).  
 
 
Fig. 2. gp130/LIF dependent PI3K/AKT signalling 
As mentioned before GSK3 inhibition together with ERK inhibition promotes self-renewal in 
absence of LIF and serum. It can be assumed that both the ERK and the PI3K pathways are 
important for controlling self-renewal and differentiation in ESCs (Fig. 2.).  
3. Signalling through the TGF-β pathway 
Transforming Growth Factor β (TGF-β) signalling controls diverse sets of cellular processes, 
including cell proliferation, recognition, differentiation, apoptosis, and specification of 
developmental fate, during embryogenesis as well as in mature tissues. Moreover it has 
been implicated in the progression of many cancers, functioning both as an antiproliferative 
and as a tumor-promoting factor. The TGF-β family members bone morphogenetic proteins 
(BMPs), Nodal and Activin have been implicated in the development and maintenance of 
various stem cells, including ESCs.  
BMP, Nodal and Activin act through the transmembrane type I and type II serine/threonine 
kinase receptors, leading to their dimerization. The activated receptor recruits SMAD 
molecules, which carry then the signal from the cell surface to the nucleus. SMAD molecules 
can be divided into three classes: the receptor-regulated SMAD (R- SMAD), the Co- SMAD, 
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and the inhibitory SMAD. The R- SMAD are transcription factors and the group is 
composed of the SMAD1, -2, -3, -5 and -8. They are activated through direct 
phosphorylation by the type I receptor and one of their functions is to translocate to the cell 
nucleus, where they form heteromeric complexes with SMAD4, the only member of the Co-
SMAD. Formation of the complex in the nucleus induces association with many DNA 
binding partners, thereby regulating the transcription of target genes both positively and 
negatively. The members of the inhibitory SMADs are SMAD6 and SMAD7, they antagonize 
the TGF-β signalling by binding to the receptor-regulated SMAD and therefore limiting 
their ability to interact with Co-SMAD and form the transcriptionally active complex (Fig. 
3.).  
In the following paragraphs we will review the most important functions of the BMP and 
the Nodal/Activin pathways in regulating pluripotency in ESCs.  
3.1 The BMP/SMAD pathway 
It has been shown that in serum-free culture, LIF is insufficient to maintain the 
undifferentiated state of murine ESCs (Ying et al., 2003). On the other hand the 
overexpression of STAT3 alone is enough to sustain pluripotency in ESCs in a LIF-
independent manner, however in presence of serum and feeders (Cinelli et al., 2008; 
Matsuda et al., 1999). These observations suggest that there must be other factors in the 
serum or produced by the feeders, which suppress differentiation and concomitantly, 
efficiently sustain self-renewal in ESCs. One of these signals was shown to be the bone 
morphogenetic proteins (BMPs). BMPs bind to the Activin receptor-like kinases (ALKs) 
ALK2, ALK3, and ALK6, and activate the Inhibitor of differentiation (Id) genes through the 
activation of the receptor-regulated SMAD2, SMAD5 and SMAD8 (Fig. 3.) (Ying et al., 2003). 
 
 
Fig. 3. Signalling through the TGF-β pathway: Nodal, Activin and BMP 
In a serum-free culture, ESCs differentiate into neural precursors under the influence of 
autocrine FGF signal even in presence of LIF (Ying and Smith, 2003) indicating that other 
signals are required for suppressing neural differentiation (Ying et al., 2003). The combination 
of LIF and BMP4 or BMP2 was found to be sufficient to maintain the undifferentiated state of 
ESCs in serum-free medium (Ying et al., 2003). However, withdrawal of LIF and retention of 
BMP causes differentiation into epithelial-like cells, leading to the conclusion that the self-
 Embryonic Stem Cells: The Hormonal Regulation of Pluripotency and Embryogenesis 
 
36 
renewal response to BMP is dependent on continuous LIF signalling and that the BMP main 
function is therefore to antagonize the neural differentiation induced by LIF in absence of 
serum (Ying and Smith, 2003). This was corroborated by the fact that ID overexpression in 
ESCs enables serum-free self-renewal in the sole presence of LIF. Upon LIF withdrawal, ID 
overexpressing cells differentiated into non-neuronal precursors, therefore demonstrating 
that these genes contribute to the ESCs self-renewal by complementing the blockade of other 
lineages induced by STAT3. Interestingly, overexpression of Nanog rendered BMP or serum 
requirement dispensable. These findings were partially explained by a constitutively high Id 
expression in these cells, which probably allowed bypassing the BMP signalling thus 
maintaining ESCs undifferentiated (Ying and Smith, 2003). However these cells were induced 
to differentiate upon BMP stimulation, indicating that Nanog cannot inhibit in an unlimited 
manner SMAD-induced differentiation pathways.  
These findings clearly indicate that the cooperation between LIF/STAT3 and BMP/SMAD 
pathway is required for maintaining ESCs in serum-free media. Nevertheless the balance 
has to be critically regulated, since depletion of the LIF/STAT3 signalling induces BMP-
dependent promotion of differentiation and overexpression of SMAD1/4 overrides the 
effect of LIF and causes non-neural differentiation (Ying and Smith, 2003). Recapitulating, 
high expression of BMP leads to differentiation into mesoderm and endoderm lineages, 
whereas neural differentiation is suppressed. On the other side, low level of BMP also 
induces differentiation into mesoderm. Therefore, support of pluripotency by BMP pathway 
is highly dose-dependent and needs to be counter-regulated by STAT3  signalling.  
However, STAT3 is not the only factor that interacts with BMP, Nanog was also proven to 
bind to SMAD1 thereby suppressing the formation of the active complex with SMAD4 
(Suzuki et al., 2006b). Nanog blocks BMP-induced mesoderm differentiation by binding to 
SMAD1 and therefore interfering with the recruitment of the co-activator and blocking the 
transcription of downstream targets responsible for BMP-induced mesodermal specification 
(Suzuki et al., 2006b). The Nanog promoter contains predicted binding-sites for both STAT3 
and Brachyury T, an early mesoderm marker. ESCs transfection with a luciferase construct 
containing the regulatory sequence, which included both STAT3- and Brachyury T-binding 
sites, resulted in LIF concentration dependent increase in transcription. The enhancer 
activity of this region was lost when one or the other binding-site on the Nanog promoter was 
mutated. Immunoprecipitation assays confirmed then the association of Brachyury T and 
STAT3, interestingly only after stimulation of the cells with LIF. These results demonstrated 
that through a cooperative action STAT3 and Brachyury T induced Nanog expression in cells 
that are initiating to differentiate into mesodermal lineage (Suzuki et al., 2006b).  
The p300 protein is an important nuclear factor in the BMP pathway. It interacts with the 
active R-SMAD and SMAD4 and regulates gene transcription (Fig. 3.). Nanog was found to 
interfere with the recruitment of the co-activator p300 to the SMAD complex, therefore 
negatively regulating BMP signalling. Suzuki et al. demonstrated that Nanog inhibits 
Brachyury T expression by inhibiting the formation of active SMAD/p300 complexes, and 
therefore maintaining the undifferentiated state of ESCs (Suzuki et al., 2006b). This study, in 
contrast to the results shown by Ying et al., links BMP signalling more to the differentiation 
processes than to the maintenance of pluripotency. Ying et al. worked with low 
concentration of BMP and in presence of LIF; these conditions maintain pluripotency and 
inhibit mesoderm differentiation (Ying et al., 2003) whereas Suzuki et al. demonstrated with 
their studies that this mesoderm-inhibition is in part due to a negative effect mediated by 
Nanog and Brachyury T (Suzuki et al., 2006b). 
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BMP proteins can bind to the type I ALK3 receptor and to the type II BMPRII receptor (Fig. 
3.). Different studies showed that in vivo embryos lacking one of these two receptors die 
because they are unable to undergo gastrulation (Beppu et al., 2000; Mishina et al., 1995), 
highlighting the essential role of BMP during embryogenesis. The impossibility of 
generating embryos carrying these mutations leads to the lack of the respective ESCs with 
the only exception of Smad4 knockout embryos which die before embryonic day 7.5 and 
therefore allow the isolation of blastocyst stage embryos and the establishment of viable 
ESCs (Sirard et al., 1998). SMAD4 as mentioned before is the co-activator molecule, which 
binds to R-SMADs for forming the active transcriptional complex. These results suggest that 
there is a SMAD-independent mode of BMP action in the embryos but also in the ESCs. Alk3 
receptor null blastocysts are morphologically identical to the wild type blastocysts; however 
ICMs of the knockout embryos fail to expand once in culture. By incubating Alk3 knockout 
ESCs with an inhibitor for ERK and p38 MAPK pathways Qi and colleagues established and 
expanded these cells in vitro in absence of BMP4. They concluded that BMP4 supports self-
renewal by inhibiting the mitogen-activated protein kinase MAPK/ERK pathway (Qi et al., 
2004). Anyway the mediators of this inhibition have still to be identified. A more recent 
study suggests that in the BMP4-induced maintenance of the undifferentiated ESCs status, 
together with the SMAD proteins, also the PI3K/AKT and the WNT pathway are involved 
(Lee et al., 2009). 
All together these data confirm the complexity of the BMP signalling, where depending on 
its expression level, presence of active interaction partners in different pathways, and timing 
of expression during embryogenesis; it strongly influences cell fate decisions both in vivo 
and in vitro. 
3.2 The Nodal/Activin pathway 
Nodal and Activin ligands bind to the type I and II Activin receptor-like kinases ALKs 
(ALK4, -5, and -7), which phosphorylate SMAD proteins to regulate gene expression. 
Nodal/Activin signals are received by the transcription factors SMAD2 and SMAD3, which 
form complexes with the Co-SMAD4 and are then translocated to the nucleus where they 
associate with other cofactors to regulate target gene transcription (Fig. 3.). Nodal/Activin 
signalling is antagonized by Lefty, an extracellular molecule or by the classical TGF-β 
inhibitor SMAD7. In vivo this pathway has been shown to be essential for the induction of 
mesoderm and endoderm lineages and for the determination of the left-right axis during 
embryogenesis. Nodal knockout show a reduced epiblast cell population that display very 
low expression of the pluripotency marker OCT3/4 and arrest the development before 
gastrulation (Robertson et al., 2003).  
Nodal expression in mouse ESCs is high, and was found to build an active signalling 
together with SMAD2. Thus, stimulation of ESCs with Activin or Nodal leads to an increase 
in SMAD2 phosphorylation and a higher ESCs proliferation, whereas inhibition of SMAD2 
activation reduces cell proliferation (Ogawa et al., 2007).  
In serum-containing medium, both BMP and Nodal/Activin pathways are autonomously 
activated in ESCs. Ogawa and colleagues showed that after overexpression of the inhibitors 
SMAD6 and SMAD7, ESCs proliferation significantly decreased, the effect in SMAD7 
transfected ESCs being much more dramatic. It is known that SMAD6 predominantly 
inhibits BMP-mediated signalling, whereas SMAD7 blocks both BMP and Nodal/Activin 
pathways. The SMAD7-dependent inhibition of cell proliferation was reversible after 
excision of the transgene; moreover this was not affecting ESCs pluripotency since injection 
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of the SMAD7-reverted cells produced live chimeras (Ogawa et al., 2007). In serum-free 
medium the SMAD7 induced blockade of proliferation is more reduced, leading to the 
conclusion that soluble TGF-β-related molecules in the serum are also involved in the 
SMAD7-dependent growth inhibition (Ogawa et al., 2007). In fact, addition of exogenous 
Activin or Nodal to the serum-free medium caused SMAD2 activation and restored cell 
proliferation; this was not observed when soluble BMP4 was added to the medium. These 
results suggested that Nodal and Activin promoted ESCs proliferation through the 
canonical pathway. Further analyses demonstrated that ESCs autonomously activate 
Nodal/Activin signalling by producing these ligands in serum-free conditions; in presence 
of serum the soluble TGF-β-related molecules might increase the endogenous 
Nodal/Activin activity leading to an enhanced cell proliferation (Ogawa et al., 2007).  
Another recent work showed that Nodal signalling acts also through the BMP pathway for 
regulating self-renewal in ESCs (Galvin et al., 2010). In this study it was observed that 
treatment of the cells with a chemical SMAD2 inhibitor resulted in an enhanced BMP 
signalling. The authors found SMAD7 to be the critical component of the Nodal pathway 
that influences BMP signalling through the regulation of Id genes (Galvin et al., 2010). 
Although many efforts have been made in order to elucidate the function of Nodal/Activin 
in mouse ESCs, future work will be needed to determine the molecular mechanisms by 
which this pathway maintains pluripotency. If the involvement of the Nodal/Activin 
pathway in maintaining mouse ESCs has still not been completely elucidated, this is not the 
case for human ESCs (hESCs). In this article we review the molecular mechanisms of 
pluripotency in ESCs generated from the mouse, being murine ESCs the most investigated 
cells. Nevertheless it is to mention that the Nodal/Activin pathway plays a fundamental 
role in the maintenance of pluripotency in hESCs. Like mouse ESCs, hESCs do express all 
the components of the LIF/STAT3 pathway but in contrast to the mouse cells, cannot be 
maintained pluripotent in presence of LIF (Humphrey et al., 2004). This indicates that 
signalling through this pathway is insufficient to prevent differentiation of hESCs and 
suggests the existence of other pathways involved in the regulation of pluripotency in 
hESCs. Interestingly, mouse epiblast stem cells derived from the E5.5-E6.5 post-implantation 
embryos, can also not be maintained undifferentiated in presence of LIF or BMP4. Like 
hESCs, mouse epiblast stem cells require FGF4 and Nodal/Activin signalling for self-
renewal (Brons et al., 2007; Tesar et al., 2007).  
In conclusion, even though all the components of the Nodal/Activin pathway are highly 
expressed in both hESCs and mouse ESCs, the outcome of these signalling is different in the 
two species. More studies are needed for a better determination of the target genes activated 
by the Nodal/Activin pathway; nevertheless it is clear that the TGF-β signalling is a critical 
regulator of stem cell functions.  
4. The canonical WNT pathway 
The WNT pathway plays crucial roles in controlling genetic programs of embryonic 
development and adult homeostasis. WNT signals are transduced depending on their 
functions through different receptors and members: The canonical WNT pathway is known 
to be involved in transmitting signals for cell fate determination, whereas the non-canonical 
WNT pathway is involved in controlling cell movements and tissue polarity. In the context 
of maintaining pluripotency in ESCs, we will focus in the next paragraph only on the 
canonical pathway.  
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Canonical WNT signalling starts when the extracellular WNT ligand binds members of the 
Frizzled and LDL receptor family. The main player of the cascade is the cytoplasmic protein 
β-catenin. When the WNT ligand activates the pathway, β-catenin translocates to the 
nucleus where it interacts with other members of the signalling pathway for activating 
target genes. The tumour suppressor adenomatous polyposis coli (APC) and AXIN are two 
components of the cytosolic destruction complex responsible for β-catenin degradation in 
absence of WNT ligand. Casein kinase Iα (CKIα) and glycogen synthase kinase 3β (GSK3β) 
kinases are also part of the destruction complex and specifically phosphorylate β-catenin 
(Fig. 4.). This is the signal for ubiquitin ligases, which target β-catenin for proteasomal 
degradation: Therefore in absence of ligands β-catenin is constantly degraded. On the 
contrary, in presence of WNT ligands, the membrane receptor LRP5/6 is phosphorylated 
and bound by Dishevelled (Dsh) and AXIN, which cannot form the destruction complex 
therefore leading to an accumulation of cytosolic β-catenin. Free β-catenin can enter the 
nucleus where it binds to the T-cell factor/lymphoid enhancer factor (TCF/LEF) family of 
transcription factors (Fig. 4.). The β-catenin-TCF/LEF complex can then activate the 
transcription of WNT target genes. In absence of β-catenin the TCF/LEF factors are 
associated with histone deacetylase 1 (HDAC1), forming a complex that promotes gene 
expression silencing (Kioussi et al., 2002). Once β-catenin is again present it replaces HDAC1 
promoting gene expression.  
 
 
Fig. 4. The canonical WNT pathway 
Several publications support the role of the WNT/β-catenin pathway in maintaining 
pluripotency in ESCs, although the precise mode of action needs still to be clarified. A 
potential source of WNT ligands is represented by the feeders used for the cultivation of 
ESCs. A functional screening of different sub-lines of STO feeders, which showed variable 
ability in maintaining ESCs self-renewal, identified WNT5A and WNT6 ligands to be the 
determinant factors. Their overexpression in STO feeders is sufficient to maintain ESCs 
undifferentiated in serum-containing medium and in absence of LIF (Hao et al., 2006). But 
also WNT3 and WNT3A are able to prevent ESCs differentiation under the same conditions; 
an effect that can be neutralized by WNT inhibitor. Moreover, ESCs conditionally 
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expressing a constitutive active form of β-catenin were able to maintain the undifferentiated 
state in a LIF-independent manner (Hao et al., 2006). This study demonstrated that the 
WNT-mediated maintenance of pluripotency was depending on β-catenin stabilization. 
Moreover constitutive activation β-catenin induced an upregulation of STAT3 mRNA and 
protein. In serum-free medium the WNT pathway is not sufficient for sustaining ESCs self-
renewal, however if 10 U/ml of LIF are added to the medium, ESCs form compact colonies 
and show OCT3/4 expression suggesting a synergistic effect of both pathways; the WNT 
pathway effectively upregulating STAT3 mRNA and the LIF pathway phosphorylating the 
protein and finally activating STAT3 target gene expression (Hao et al., 2006).  
Nevertheless cultivation of ESCs in a feeder- and serum-independent manner with the sole 
presence of WNT3A conditioned medium is also not sufficient for maintaining ESCs 
undifferentiated; this is only possible in combination with LIF (10U/ml). The same holds 
true  when ESCs constitutively express an active form of β-catenin (Ogawa et al., 2006). 
In β-catenin knockout ESCs the expression of the core pluripotency factors Nanog, OCT3/4 
and SOX2 is still present indicating that β-catenin regulates the expression of several 
stemness genes, but is not directly required for maintenance of pluripotency (Anton et al., 
2007). Undifferentiated ESCs were shown to accumulate β-catenin in the nucleus (Naito et 
al., 2006; Takao et al., 2007). It was therefore investigated if the β-catenin-mediated 
expression of pluripotency factors was controlled through the interaction with TCF/LEF 
transcription factors. The TCF/β-catenin-mediated gene regulation in ESCs was measured 
by comparing endogenous TOPFlash activity with a FOPFlash reporter. Interestingly a very 
minimal TCF/β-catenin activity was detected with this method, indicating that probably β-
catenin might interact with factors other than TCF for inducing pluripotency-related gene 
expression (Anton et al., 2007). Actually other reports demonstrated the interaction of β-
catenin with well-known pluripotency factors, such as KLF4, SOX2, and OCT3/4. The 
expression level of β-catenin was found not to be regulated through the LIF/STAT3 
pathway, since LIF depletion for 4 days did not change the mRNA and protein level of β-
catenin (Takao et al., 2007). However in the same cells, the amount of β-catenin found 
exclusively in the nuclei was reduced when compared to the one of ESCs cultivated in 
presence of LIF. Also by forced expression of an active form of β-catenin, the same authors 
could cultivate ESCs in absence of LIF. Interestingly, they found Nanog and OCT3/4 to be 
upregulated in the β-catenin transgenic ESCs compared to the wild type. On the other hand 
they noticed that after withdrawal of LIF for 3 and 6 days, Nanog and β-catenin expression 
disappeared at day 3 whereas OCT3/4 expression was decreasing at day 6. These 
observations suggested the possibility that Nanog could be a potential target of β-catenin 
(Takao et al., 2007). By luciferase assay Nanog promoter activity was examined in ESCs 
carrying the constitutive active form of β-catenin. In presence of LIF these cells showed 
higher promoter activity compared to the wild type cells. Furthermore, upon LIF 
withdrawal the Nanog promoter was shown to be still highly active, whereas wild type cells 
lost its expression and differentiated. Nanog mRNA level correlated with the promoter 
activity, leading to the hypothesis that Nanog promoter contains a β-catenin-responsive 
element (Takao et al., 2007). Moreover, it was previously shown that the Nanog promoter 
contains OCT3/4-SOX2 binding sites at the promoter region (-322/+50) (Kuroda et al., 2005; 
Rodda et al., 2005). Mutations in this promoter region in ESCs expressing the active form of 
β-catenin showed reduced Nanog reporter activity in both conditions, with and without LIF, 
suggesting a reduced β-catenin transcriptional activity. The presence of OCT3/4-SOX2 
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binding region on the Nanog promoter is indispensable for the β-catenin-mediated 
upregulation of Nanog. These results aroused the question if β-catenin could physically 
interact with OCT3/4. Pull-down assay confirmed this hypothesis when OCT3/4 was found 
co-precipitated with β-catenin (Takao et al., 2007). The discrepancy in the results between 
the Takao and the Ogawa work could be due to the use of different cell lines.  
We can conclude that the WNT/β-catenin signalling helps in the maintenance of 
pluripotency, nevertheless β-catenin alone is not sufficient to maintain the cells in a 
completely undifferentiated state.  
5. Transcription factors that regulate pluripotency in ESCs 
A critical role in maintaining ESC identity is played by a set of transcription factors centred on 
the octamer binding protein 3/4 (OCT3/4) (Nichols et al., 1998; Schöler et al., 1989), the SRY-
related HMG-box gene 2 (SOX2) (Yuan et al., 1995), and Nanog (Chambers et al., 2003; Mitsui 
et al., 2003). Genome-wide studies have highlighted the co-localization of these three 
transcription factors in ESCs chromatin increasing the complexity of the transcriptional 
networks that direct ESC identity. The following paragraphs review the current knowledge on 
the molecular functions and regulation of the transcription factors OCT3/4, SOX2, and Nanog. 
5.1 The transcription factor OCT3/4 
OCT3/4 is a member of the POU transcription factor family; it recognizes an 8-base pairs 
DNA sequence found in the promoters and enhancer regions of many ubiquitously 
expressed and cell-specific genes (Ruvkun and Finney, 1991). The gene encoding OCT3/4 is 
named Pou5f1. OCT3/4 was first identified as an active binding factor in the extract of 
undifferentiated embryonic stem and embryonal carcinoma cells (Lenardo et al., 1989; 
Schöler et al., 1989). The presence of OCT3/4 protein in ESCs and embryonal carcinoma cells 
first suggested an association with the early stage of mouse embryogenesis. During the 
mouse development, it is first detected in oocytes and its expression declines during the first 
two embryonic divisions, but it reappears at the 4-8 cell-stage, where it is expressed in all 
the nuclei. Subsequently it is reduced in the trophectoderm and becomes restricted to the 
ICM. In the post-implantation embryos, OCT3/4 is localized in the epiblast but disappears 
as cells undergo differentiation, with expression persisting in the germ cells (Palmieri et al., 
1994). The importance of OCT3/4 during early embryogenesis was also highlighted by the 
fact that embryos lacking the Pou5f1 gene die after implantation (Nichols et al., 1998) due to 
the absence of the ICM. Using a conditional expression and repression system in ESCs, the 
requirement of OCT3/4 in the maintenance of developmental potency was determined 
(Niwa et al., 2000). A critical amount of OCT3/4 is needed to sustain self-renewal, and up- 
or downregulation induces differentiation of the ESCs. Overexpression of this factor 
promotes differentiation into primitive endoderm and mesoderm, whereas repression of it 
causes loss of pluripotency and differentiation into trophectoderm (Fig. 5.). Effectively, in 
vivo OCT3/4 is abundant in the ICM cells of the blastocyst and down-regulated in the 
trophectoderm, whereas in the primitive endoderm the level of expression increases 
(Palmieri et al., 1994). These findings highlight the fundamental function of OCT3/4 in 
preventing dedifferentiation of epiblast cells or of ESCs into trophectoderm lineage.  
Exogenous expression only of OCT3/4 is sufficient to generate pluripotent stem cells from 
mouse neural stem cells (Kim et al., 2009) and together with three other transcription factors 
it is essential in the reprogramming of somatic cells into the pluripotent state (Nakagawa et 
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al., 2008; Takahashi and Yamanaka, 2006). While the other factors involved in 
reprogramming are replaceable by family members or other factors, without OCT3/4 no 
reprogramming occurs (Nakagawa et al., 2008). Moreover knockdown experiments in ESCs 
showed a very dramatic change in gene expression compared to the one caused for example 
by Nanog or SOX2 knockdown (Ivanova et al., 2006) implying OCT3/4 as a chief selector for 
ESC fate decision.  
LIF/STAT3 signalling does not directly support ESCs renewal by maintaining OCT3/4 
expression, but it has been shown that STAT3 and OCT3/4 share some target genes 
involved in maintaining pluripotency. It is the case for the embryonic ectoderm 
development (Eed) gene, which was shown to be a common downstream target of both 
transcription factors (Ura et al., 2008). EED is a major component of the Polycomb repressive 
complex 2 (PRC2), which is involved in the methylation of lysine 27 on the histone H3 
(H3K27). As we will describe later epigenetic mechanisms, like dynamical modification of 
the chromatin, play a fundamental role in maintaining pluripotency and controlling 
differentiation. EED function is to silence the expression of differentiation-associated genes 
in self-renewing ESCs and its downregulation induces differentiation (Boyer et al., 2006). 
Expression of a dominant negative form of STAT3 was shown to induce downregulation of 
EED, whereas overexpression of STAT3 caused an upregulation. Similar results were found 
when OCT3/4 was downregulated, suggesting Eed to be a common downstream target of 
both transcription factors (Ura et al., 2008). Further analyses confirmed that STAT3 and 
OCT3/4 directly bind the promoter region of the Eed gene, regulating its expression and 
thereby inducing silencing of differentiation-associated genes.  
Ura et al. found that self-renewal correlates with the presence of high concentration of 
methylated H3K27 that leads to the transcriptional repression of the gene carrying this 
signal. Elimination of STAT3 and OCT3/4 causes a reduction of this methylation on the 
promoter of differentiation marker genes. These results suggested that EED is involved in 
STAT3- and OCT3/4-dependent gene silencing of differentiation markers and highlight 
another important function of OCT3/4 transcription factor in maintaining and controlling 
pluripotency in ESCs.  
Of the known OCT3/4 target genes, four have been shown to be essential for the 
maintenance of pluripotency: Sox2, the undifferentiated transcription factor 1 (Utf1), 
Rex1/Zfp42 and Nanog. The regulatory regions of these genes contain an octamer element 
capable of binding OCT3/4. As we will describe in the following paragraphs, Sox2 is not 
only an OCT3/4 target gene but also serves as a cofactor for OCT3/4 (Okumura-Nakanishi 
et al., 2005). Although OCT3/4 and SOX2 have independent roles in determining other cell 
types, in pluripotent cells they act synergistically to drive transcription of their target genes. 
Furthermore, this complex was found to promote transcription of the Nanog homeoprotein 
(Rodda et al., 2005) (Fig. 5.). 
5.2 The transcription factor SOX2 
SOX2 is a member of the sex-determining region of the Y chromosome-related (SRY-related) 
high-mobility group (HMG) box (SOX) family of transcription factors. SOX2 has an 
expression pattern similar to that of OCT3/4 through the mouse preimplantation 
development. SOX2 expression is also associated with precursor cells of the developing 
central nervous system and indeed can be used to isolate these cells. Like OCT3/4, 
downregulation of SOX2 correlates with a commitment to differentiation and is no longer 
expressed in cell types with restricted developmental potential. The phenotypic lethal 
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consequences of the absence of SOX2 expression in the embryo are in contrast to OCT3/4, 
visible only after implantation (Avilion et al., 2003). This is due to an accumulation of 
maternal SOX2 in the cytoplasm of the oocytes, which persist in all cells at least until the 
blastocyst stage, and not like OCT3/4 maternal transcripts, which last only till the 2-cell 
stage embryo (Palmieri et al., 1994). Thus, mutant embryos lacking the Sox2 gene die 
presumably when the maternal SOX2 becomes diluted causing the differentiation of the 
epiblast cells into trophectoderm or extraembryonic ectoderm (Avilion et al., 2003) (Fig. 5.).  
 
 
Fig. 5. OCT3/4, SOX2, Nanog core transcription factors: regulatory circuitry 
As mentioned before, loss of OCT3/4 causes differentiation of the epiblast cells into 
trophectoderm derivatives (Niwa et al., 2000). Avilion et al. proposed that the presence of 
both transcription factors is required for the formation and maintenance of epiblast cells. An 
upregulation of OCT3/4 and the accompanying downregulation of SOX2 lead to the 
extraembryonic ectoderm differentiation. 
We know that the regulatory regions of the Sox2 gene contain an octamer element capable of 
binding OCT3/4 (Tomioka et al., 2002; Yuan et al., 1995). A possible interaction of these two 
factors was also proposed by the fact that almost all the SOX2-OCT3/4 target genes have 
both the octamer and sox heptamer elements separated by either 0 or 3 base pairs (Reményi 
et al., 2003; Williams et al., 2004). The Pou5f1 gene has different regulatory regions that are 
important for its expression. The distal enhancer, which contains the conserved region CR4, 
was shown to be required for ESC-specific OCT3/4 expression (Nordhoff et al., 2001). Two 
regulatory regions (the SRR1 and SRR2), known to confer ESC-specific expression, were also 
found in the Sox2 sequence. Using a ChIP assay Chew et al. first demonstrated that SOX2 
and OCT3/4 interact with the enhancers of Pou5f1 and Sox2 genes. Moreover OCT3/4 and 
SOX2 knockdown experiments showed a reduced enhancer activity, confirming that both 
factors positively control their reciprocal expression (Chew et al., 2005). The same authors 
hypothesized a transcriptional regulatory network consisting of auto-regulatory and multi-
component loops. In an auto-regulatory system the gene product binds to its own regulatory 
element allowing its continued and stable expression. In a multi-component system, the 
OCT3/4 factor binds to the Sox2 regulatory element and vice versa generating a bi-stable 
system with the possibility to switch between the two different states (Chew et al., 2005) 
(Fig. 5.).  
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We described before that Sox2 null embryo die after implantation, because of differentiation 
of the epiblast cells. The same findings are reproducible also in vitro, where ESCs lacking 
Sox2 gene differentiate primarily into trophectoderm-like cells. Thus, SOX2 was defined to 
be indispensable for maintaining ESCs pluripotency. However, the transcription of many 
OCT3/4-SOX2 target genes was not affected in ESCs null for Sox2. These findings suggested 
that SOX2 regulates the expression of OCT3/4 through the regulation of multiple 
transcription factors (Masui et al., 2007). So, it seems that the main contribution of SOX2 in 
ESCs is to maintain OCT3/4 expression. Consistent with this idea is the finding that 
enforced expression of OCT3/4 can rescue ESCs from differentiation induced by the loss of 
Sox2 (Masui et al., 2007). Not to forget is also that SOX2 is one of the four transcription 
factors, which together are able to induce reprogramming to pluripotency in differentiated 
cells (Takahashi and Yamanaka, 2006). Furthermore, large-scale ChIP studies have shown 
the OCT3/4-SOX2 complex closely localized to another important regulator of pluripotency, 
the Nanog transcription factor.  
5.3 The transcription factor Nanog 
Nanog is a homeodomain protein, which acts as an intrinsic effector of ESCs self-renewal. 
Nanog was detected in ESCs, embryonic carcinoma cells, and in the embryonic germ cells. 
During ESCs differentiation, Nanog mRNA declines markedly, and its expression is 
retained only in undifferentiated cells. In the mouse embryo its first expression appears in 
the compacted morula and it is localized to the interior cells, the future ICM. In blastocysts, 
the expression is confined to the ICM and absent from the trophectoderm. In the later 
blastocyst, Nanog is further restricted to the epiblast and excluded from the primitive 
endoderm; it is then down regulated after implantation (Chambers et al., 2003; Mitsui et al., 
2003). At day E11.5-E12.5 Nanog expression marks the pluripotent germ cells. 
Overexpression of Nanog in ESCs was found to allow proliferation of undifferentiated ESCs 
in absence of LIF and as well as in the presence of the LIF-antagonist hLIF-05, which blocks 
the activity of all known LIFR ligands (Chambers et al., 2003). After transfection with Cre-
recombinase, in which the Nanog expression cassette had been eliminated, these cells 
reverted to LIF-dependence, demonstrating that this phenotype was directly attributable to 
Nanog overexpression. Following exposure to a differentiation-promoting agent, like 
retinoic acid, cells overexpressing Nanog remained, in contrast to the Cre-reverted cells, 
morphologically undifferentiated and expressed OCT3/4. Cre-reverted cells were injected 
into mouse blastocysts and contributed to the generation of germline competent chimeras. 
Even though cells overexpressing Nanog self-renew in a cytokine independent manner, the 
presence of LIF confers to these cells an enhanced self-renewing capacity (Chambers et al., 
2003).  
A reduction in the level of Nanog causes ESCs to differentiate to extraembryonic endoderm 
lineages (Chambers et al., 2007; Ivanova et al., 2006) (Fig. 5.). In vivo the absence of Nanog 
during embryo development results in early lethality. At developmental day E5.5 the 
mutant embryos showed disorganized extraembryonic tissues with no discernible epiblast 
or extraembryonic ectoderm. ICM of Nanog null blastocysts failed to proliferate and 
differentiated into parietal endoderm-like cells, demonstrating that its expression is essential 
for maintenance of pluripotency of the ICM cells (Mitsui et al., 2003). Interestingly, ESCs 
upon targeted deletion of the Nanog gene can self-renew indefinitely and can contribute to 
the generation of chimeric animals (Chambers et al., 2007). This indicates that loss of Nanog 
in ESCs does not affect pluripotency once this was established. Nevertheless, even though 
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Nanog null cells colonize the germ layers of the chimeric mice and they are recruited to the 
germ line, primordial germ cells lacking Nanog fail to mature on reaching the genital ridge 
(Chambers et al., 2007). These data confirm that Nanog is specifically required for the 
formation of germ cells.  
The fact that STAT3 activation in presence of LIF was not increased in cells overexpressing 
Nanog (Mitsui et al., 2003) and the fact that these cells did not differentiate in presence of a 
JAK/STAT3 inhibitor (Chambers et al., 2003), clearly demonstrate the existence of a parallel 
and LIF/STAT3-independent mechanism sustaining pluripotency in ESCs. In vivo these 
findings are confirmed by the fact that Nanog is absolutely required for epiblast formation, 
while STAT3 is dispensable. Further analysis showed also that Nanog expression was not 
altered after incubation of the cells with a MEK inhibitor, indicating that Nanog-dependent 
maintenance of pluripotency was not due to a repression of the MEK/ERK pathway 
(Chambers et al., 2003). 
Several studies showed that Nanog and OCT3/4 factors overlap substantially in their target 
genes, causing sometimes, also by cooperation, the activation or suppression of the 
expression of target genes. Mapping of the binding sites of OCT3/4 and Nanog in the 
mouse ESC genome showed that a substantial proportion of the genes were occupied by 
both factors, in some cases Nanog-OCT3/4 were found to co-localize, in other cases they 
bound indepentently (Loh et al., 2006). Screening for the presence of OCT3/4 and Nanog 
binding sites after differentiation revealed an enrichment of OCT3/4 or Nanog-bound genes 
that were induced and repressed upon differentiation. The majority of these genes were 
repressed and the ones that exhibited the strongest downregulation were bound by both 
factors (Loh et al., 2006). In the same study it could be shown that the OCT3/4-regulated 
target genes predominantly repress trophectoderm markers whereas Nanog activates the 
transcription of Pou5f1 and Sox2 evidencing a possible role of Nanog in controlling the levels 
of both OCT3/4 and SOX2. These factors in turn control the downstream genes involved in 
the maintenance of pluripotency or inhibition of differentiation (Loh et al., 2006). 
Interestingly promoter-sequence analyses showed the presence of a Sox-Oct element on the 
Nanog promoter. Two different groups demonstrated that both OCT3/4 and SOX2 can bind 
to the Nanog promoter therefore driving its transcription (Kuroda et al., 2005; Rodda et al., 
2005).  
ESCs under conventional culture conditions (namely with serum and LIF) are in a dynamic 
state, that fluctuates between a stable state, in which Nanog expression is high, and an 
unstable state, where Nanog expression levels are low (Kalmar et al., 2009; Singh et al., 
2007). As a consequence ESCs form a heterogeneous population where pluripotent ESCs 
exhibit a highly variegated gene expression pattern. When induced to differentiate only 
ESCs with low levels of Nanog expression are able to commit in a stable manner (Chambers 
et al., 2003). This hypothesis was confirmed by a study where the two different populations 
were sorted and exposed to differentiation conditions for 3 days (Kalmar et al., 2009). The 
low-Nanog cells did not change their Nanog expression level, but lost their ability to form 
colonies and showed neuronal differentiation. On the contrary only a very small part of the 
high-Nanog cells differentiated and showed reduced Nanog expression. Nevertheless, it 
seems that both cell types are able to switch from one to the other condition. Moreover the 
smaller proportion of low-Nanog cells suggests that this could be a transient, short-lived 
event in the cells. Cultivation of low-Nanog cells population for 24h in conventional culture 
conditions proved this hypothesis. A subpopulation of cells showed Nanog distribution like 
the high-Nanog population, confirming that low-Nanog expression is an instable state of the 
 Embryonic Stem Cells: The Hormonal Regulation of Pluripotency and Embryogenesis 
 
46 
cells. The same experiment performed only with the high-Nanog cells did not give rise to a 
subpopulation expressing low level of Nanog, confirming that this is the most stable state. 
The levels of Nanog expression in an ESC are related to its probability to differentiate or not. 
In this model the advantage is that in a heterogeneous population, there is always a 
subpopulation of cells pre-primed for differentiation. Such priming would be an advantage 
in situations where the cells must be ready within a short period to respond to diverse 
signalling (Kalmar et al., 2009).  
Although there are other transcription factors associated with ESC self-renewal and 
pluripotency, a large number of studies support the notion that the trio SOX2, OCT3/4 and 
Nanog are the main regulators that generate and maintain the pluripotent state in vivo and 
in vitro. This idea is also corroborated by the fact that all three factors play an essential role 
in reprogramming somatic cells (Meissner et al., 2007; Okita et al., 2007; Takahashi and 
Yamanaka, 2006).  
6. Regulation of pluripotency by epigenetic mechanisms 
In the following paragraph we will discuss some of the emerging evidence of the interaction 
between the core transcription factors and the epigenetic machinery, which together 
regulate stem cell pluripotency and differentiation. We will focus on the principal epigenetic 
modifications and how these influence and regulate the effect of pluripotency factors like 
Nanog, OCT3/4 and STAT3.  
Epigenetic is the study of inherited changes in phenotype or gene expression caused by 
mechanisms other than changes in the underlying DNA sequence. Non-genetic factors cause 
cell’s genes to behave differently and these changes may remain through cell divisions. The 
main known epigenetic mechanisms affecting transcription of the genes are: DNA 
methylation of the CpG islands, modifications of the histones, chromatin remodelling, and 
small RNA molecules. These modifications induce conformational changes in the chromatin 
structure: High-condensed chromatin, the so-called heterochromatin, is resistant to 
transcriptional activation, whereas the more open euchromatin allows transcription factors 
to bind on the DNA and drive the transcription of genes. Transcription factor regulation of 
gene expression and chromatin-controlled epigenetic memory systems are closely 
cooperating in establishing the pluripotent state of ESCs and in maintaining the cell fate 
decisions throughout development of an organism. ESCs are, in contrast to differentiated 
cells, highly transcriptional active. This implies that differentiation processes involve 
downregulation of general transcriptional activity. Therefore differentiation leads to a 
decrease in the euchromatic nature of the chromosome rendering it more condensed and 
less accessible for the transcriptional machinery; the resulting heterochromatin leads to a 
loss of pluripotency.  
Histone proteins are subjected to various posttranslational modifications. The N-terminal 
tails of core histones H2A, H2B; H3 and H4 can be for instance acetylated, methylated, 
ubiquitinated, and phosphorylated. All these modifications modulate and control the 
conformation of chromatin, and therefore the transcription of the genes (Margueron et al., 
2005). For example two important heterochromatic markers are increased trimethylated 
lysine 9 on the histone 3 (TriMeK9 H3) and decreased acetylated histone H3 and H4 (AcH3 
and AcH4) (Kimura et al., 2004). When these conditions are global, they cause gene 
repression. These modifications can spread over kilobases of genomic DNA and are 
transmitted to daughter cells: This is the concept of the epigenetic inheritance (Cavalli and 
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Paro, 1999). Two other important histone modifications are methylation of lysine 27 on the 
histone H3 (MeK27 H3), which leads to repression of transcription; and the methylation of 
lysine 4 on the histone H3 (MeK4 H3) that positively regulates gene transcription by 
recruiting nucleosome remodelling enzymes and histone acetylases. Methylation of these 
lysines is catalyzed by thrithorax-and Polycomb-group proteins, which are involved in 
mitotic inheritance of lineage-specific gene expression programs and play therefore key 
functions during development (Plath et al., 2003; Ringrose and Paro, 2004). 
Bernstein et al. mapped the histone methylation patterns in mouse ESCs and found a novel 
chromatin modification pattern, the “bivalent domains”, which consist of large DNA 
regions of K27 methylation and smaller regions of K4 methylation that silence 
developmental-associated genes in ESCs while keeping them in a standby mode for 
activation. The bivalent histone modification represses gene expression because of the 
dominant repressive effect of K27 methylation over the K4 methylation. Thus, when ESCs 
differentiate these genes can rapidly be activated for transcription and the typical bivalent 
status is lost. Once the cell is committed it shows either K27 or K4 methylation (Bernstein et 
al., 2006). 
The Polycomb protein complexes (PcG) are methyl-transferases responsible for methylation 
of H3K27. The main function of these complexes is to repress transcription and therefore 
maintain the cellular identity. They are fundamental during embryonic development and 
have been associated with many lineage-control gene loci in human and murine ESCs. 
Recent studies have demonstrated that in ESCs the target genes of PcG highly overlap with 
those of the core pluripotency markers: Nanog, OCT3/4, and SOX2 (Boyer et al., 2006; Lee et 
al., 2006). PcG complexes functions as two distinct components, the Polycomb repressive 
complex 1 (PRC1) and the PRC2 (Francis and Kingston, 2001). Microarray analyses with 
wild type cells and Eed (embryonic ectoderm development) null cells, a component of the 
PRC2, showed an upregulation of PcG target genes, like for example Gata3, Gata4, and Gata6 
genes. Moreover most of the PcG target genes were found upregulated upon cell 
differentiation, highlighting a fundamental role of PcG complex in silencing differentiation-
associated genes in ESCs, and therefore contributing to the maintenance of pluripotency 
(Boyer et al., 2006).  
Among the enzymes that modify histones there are also the histone demethylases, which are 
responsible for removing the methyl groups on the lysine 4 in the histone H3 (Agger et al., 
2008). The Jumonji protein family, JARID1 was shown to specifically demethylate the H3K4 
lysine, which is usually associated with active transcription (Mikkelsen et al., 2007). The 
bivalent histone modification theory suggests a mechanism where a cross talk between PcG 
and demethylases regulates transcriptional and developmental programs. Pasini and 
colleagues demonstrated that the H3K4 demethylase RBP2 (JARID1A) binds together with 
the PRC2 complex on PcG target genes effectively regulating their expression. The binding 
of RBP2 to the target genes is required for maintaining the PRC2-dependent transcriptional 
silencing (Pasini et al., 2008).  
We mentioned before that ESCs show a unique chromatin status that is characterized by 
hyperdynamic and open chromatin environment. The maintenance of transcriptional 
permissive chromatin is achieved with general low level of the repressive marks H3K9 
methylation and enrichment in active marks like methylation of H3K4 and acetylation of H3 
and H4 (Meshorer and Misteli, 2006). These epigenetic processes are required for the 
maintenance of ESCs pluripotency and plasticity. STAT3 together with OCT3/4 
transcription factors can regulate the expression of EED (Ura et al., 2008). However, the 
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enzymes that catalyze demethylation of the histones also play a fundamental role. OCT3/4 
binding sites studies revealed that this factor controls also the architecture of the chromatin 
by controlling the expression of genes that encode for histone-modifying enzymes (Loh et 
al., 2006). It was shown with ChIP assay that OCT3/4 clusters within the Jmjd1a and Jmjd2c 
histone demethylase genes and after OCT3/4 knockdown their expression was decreased 
(Loh et al., 2007). Interestingly RNAi-depletion of Nanog had no or little effect on the 
expression of both JMJD1a and JMJD2c, confirming both genes as OCT3/4 targets. Both 
JMJD1a and JMJD2c enzymes are involved in the demethylation of the repressive mark 
H3K9. ESCs differentiated upon knockdown of either JMJD1a or JMJD2c and showed 
fibroblast-like morphology (Loh et al., 2007). Search for downstream targets identified 
different genes that were down- or up-regulated depending on which Jmjd was silenced; 
only few genes were found to overlap between JMJD1a and JMJD2c (Loh et al., 2007). 
JMJD1a was found to regulate the expression of the Tcl1 gene, which is known to be 
required in pluripotent ESCs (Ivanova et al., 2006; Ivanova et al., 2002). Depletion of JMJD1a 
induced an increase of H3K9Me2 at the Tcl1 promoter, resulting in its repression and 
differentiation of the ESCs (Loh et al., 2007). Moreover it is known that Tcl1 promoter is 
bound by the OCT3/4 transcription factor (Loh et al., 2006) and it was shown that an 
increase in H3K9Me2 abolished this binding. Thus, the loss of OCT3/4 binding was 
probably the cause for downregulation of TCL1 after JMJD1a knockdown. Interestingly 
overexpression of TCL1 in ESCs rescued the effect of JMJD1a depletion, confirming Tcl1 as a 
key effector of JMJD1a. Microarray analyses showed that after JMJD2c knockdown Nanog 
expression was reduced. With ChIP assay after JMJD2c depletion an enrichment of 
H3K9Me3 on the Nanog promoter region was observed and further analyses demonstrated 
that JMJD2c directly binds to the Nanog promoter, positively regulating its expression (Loh 
et al., 2007). Like for TCL1 and JMJD1a, overexpression of Nanog in JMJD2c knockdown 
ESCs was enough for maintaining the undifferentiated state of the cells, demonstrating that 
Nanog could compensate the loss of JMJD2c. In the end, this study provided the evidence 
that the histone demethylases JMJD1a and JMJD2c help in the maintenance of pluripotency 
through the regulation of downstream genes that encode for self-renewal factors.  
Histone tails can also be acetylated by acetyl-transferases. The p300 acetyl-transferase 
catalyzes the acetylation of K9 and K14 of histone H3 which are markers of transcriptionally 
active chromatin and is required for ESCs to undergo early differentiation (Zhong and Jin, 
2009). Interestingly, deletion of p300 did not affect ESCs self-renewal and the expression of 
Nanog, OCT3/4 and SOX2. However, these cells exhibited an increase in the endoderm 
marker GATA6 and a reduction of the ectoderm marker FGF5. Embryoid bodies generated 
from the p300 null cells had a higher expression of GATA6, resulting in an overgrowth of 
extra-embryonic endoderm-like cells. Moreover Nanog but not OCT3/4 expression, was 
much more reduced both at the protein and mRNA levels compared to the wild type 
embryoid bodies. This suggested that transcription of Nanog during differentiation is 
dependent on the presence of p300. Overexpression of Nanog in p300 -/- embryoid bodies 
could in part rescue the aberrant expression of GATA6, but not for instance the one of FGF5 
(Zhong and Jin, 2009). Therefore the unusual phenotype of the knockout embryoid bodies 
could be caused by an improper regulation of Nanog during differentiation. Reporter 
activity assay demonstrated that p300 was able to control Nanog expression at the 
transcriptional level in a dose-dependent manner and independently of the presence or not 
of LIF in the medium and suggested that p300 might regulate Nanog expression through a 
regulatory element located at -3.8 to -4.8 kb. Interestingly, previous works showed that 
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STAT3 and Brachyury T bind to this region of the Nanog promoter, regulating early 
mesoderm differentiation (Suzuki et al., 2006a). By ChIP assays it was confirmed that p300 
binds to the same regulatory region  and differentiated p300 knockout ESCs show a 
significant reduction in H3K9 acetylation at the Nanog/Brachyury T/STAT3 binding site 
(Zhong and Jin, 2009). In conclusion this study demonstrated that p300 controls 
transcriptional regulation of Nanog during differentiation through epigenetic modifications 
of histone acetylation at the Brachyury T/STAT3 binding site on the Nanog promoter.  
Understanding how epigenetic mechanisms interact with pluripotency factors is of high 
interest also for the better understanding of  reprogramming processes. 
6.1 Induced pluripotent stem cells: an epigenetic revolution 
Due to the exceptional characteristics of ESCs, the possibility to generate pluripotent cells 
from fully differentiated cells by resetting their epigenetic memory has fascinated the 
scientific world for many years. Originally it was demonstrated that activated enucleated 
oocytes were able to reprogram differentiated cell nuclei and give rise to viable offspring 
(Wilmut et al., 1997) or that it was possible to achieve reprogramming of mature cells 
through fusion with ESCs (Tada et al., 2001). Recently genetic strategies were developed for 
manipulating and finally re-activating pluripotency mechanisms in terminally differentiated 
cells (Takahashi and Yamanaka, 2006; Yamanaka 2008). In the following paragraph we will 
discuss a few examples of epigenetic manipulations, which were shown to help lineage-
committed cells to re-activate pluripotency-related genes, giving rise to induced pluripotent 
stem cells (iPSCs). Yamanaka and colleagues, by transducing four transcription factors 
(OCT3/4, SOX2, KLF4, and c-MYC) into mouse fibroblasts, could reprogram these cells into 
iPSCs, which showed an ESC-like transcriptional circuitry and epigenetic landscape. 
Moreover these cells were demonstrated to be pluripotent being able in vitro to differentiate 
into cell types of the three germ layers and in vivo to contribute to germline competent 
chimeras (Maherali and Hochedlinger, 2008). 
Undifferentiated cells usually show transcriptionally highly-active chromatin, which is 
gradually condensed and therefore less transcriptionally active upon differentiation. It is 
then easy to understand that reprogramming induces marked epigenetic changes in the 
differentiated cells making them again competent to respond to pluripotency factors.  
We already discussed the importance of the transcription factors OCT3/4, SOX2, KLF4, and 
c-MYC in the context of ESCs, we therefore refer to the original paper of the Yamanaka 
laboratory for more information about how these genes were selected for generating iPSCs 
(Takahashi and Yamanaka, 2006; Yamanaka, 2008). Interestingly, the capacity of 
reprogramming differentiated cells seems not to be an exclusive characteristic of the four 
transcription factors (OCT3/4, SOX2, KLF4, and c-MYC). Other studies, in which the same 
reprogramming technique was used, demonstrated that some of the Yamanaka factors could 
be replaced (Feng et al., 2009) or used in combination with other factors (Mikkelsen et al., 
2008). Importantly only OCT3/4 was found to be indispensable for a proper reprogramming 
independently from the origin of the parental cells. Moreover by overexpression or 
knockdown of additional factors, or by using small chemical compounds it was possible to 
increase the efficiency of the reprogramming process. 
As mentioned before DNA methylation plays a fundamental role in regulating gene 
expression, since highly methylated genes are normally transcriptionally inactive. Thus, the 
first important change that has to happen in somatic cells undergoing reprogramming is a 
remodelling of the methylated sites on the chromatin. Moreover for achieving a fully 
 Embryonic Stem Cells: The Hormonal Regulation of Pluripotency and Embryogenesis 
 
50 
reprogrammed state iPSCs have to re-activate the endogenous expression of pluripotency-
related genes, establish again an open chromatin structure, and re-activate the Polycomb 
machinery in order to repress lineage specific gene expression. 
It has been shown that with the Yamanaka factors, only a small population of the 
reprogrammed cells showed reactivation of endogenous Nanog expression, contribution to 
chimera formation, and formation of teratoma. These results demonstrated that most of the 
infected cells were only partially de-differentiated and their epigenetic landscape was only 
to some extent changed but did not completely resemble the one of ESCs (Mikkelsen et al., 
2008). For example examination of the methylation state of high-CpG-Promoters (HCP), 
which are usually bivalently marked in ESCs, revealed that partially reprogrammed 
fibroblasts showed 70% more of HCP with bivalent chromatin structure when compared to 
the original parental cells. However a comparison with fully reprogrammed iPSCs showed 
that partially reprogrammed iPSC had 40% less bivalent chromatin structure (Mikkelsen et 
al., 2008). Further analyses confirmed that in partially reprogrammed cells, the 
pluripotency-related genes exhibited DNA hypermethylation instead of harbouring the 
bivalent markers typical for ESC chromatin. The first major reprogramming barrier was 
shown to be an incorrect induction of DNA methylation changes. Incomplete demethylation 
of promoters of fundamental pluripotency-related genes such Nanog or Oct3/4 leads to an 
unsuccessful reprogramming of the cells. Mikkelsen and colleagues demonstrated that 
treatment of partially reprogrammed iPSCs with a DNA methyltransferase inhibitor (5-aza-
cytidine) rapidly and fully reprogrammed these cells into authentic iPSCs (Mikkelsen et al., 
2008). Analyses of the methylation state of CpGs near to pluripotency genes such as Nanog 
and Utf1 confirmed significant demethylation. Identical results were achieved by transient 
knockdown of DNMT1 in partially reprogrammed cells. Treatment with DNA 
methyltransferase inhibitors during the reprogramming processes led to an increased 
efficiency in the generation of ESC-like colonies, however only if the treatment was started 8 
days after infection of the cells with the four reprogramming factors (Mikkelsen et al., 2008). 
Another reason why incomplete reprogramming might occur is the inappropriate activation 
or failure in the repression of endogenous cell-fate specific transcription factors, which in 
turn fail to reactivate hypermethylated pluripotency-related genes. Once more these results 
highlight the importance of a coordinated regulation of transcription factors, which have to 
be stabilized by correct epigenetic remodelling mechanisms. 
Using a chemical approach, aimed at the optimization of the reprogramming efficiency and 
at the reduction of genetic manipulations due to the integration in the genome of the 
reprogramming factors, it was demonstrated that by inhibiting G9a histone 
methyltransferase (BIX-01294) in combination with a L-calcium channel agonist (BayK), the 
reprogramming process was successfully achieved only by transfecting mouse fibroblast 
with Oct3/4 and Klf4 (Shi et al., 2008). The generated iPSCs were then expanded without the 
two chemical compounds, demonstrating that once the reprogramming has taken place, 
they are dispensable. G9a is a histone methyltransferase known to repress gene activity by 
transferring methyl groups on the histone H3 lysine 9 (H3K9) at target promoters. Bisulphite 
sequencing analyses of the Nanog promoter region confirmed that these iPSCs had 
demethylated this region allowing the re-activation of Nanog transcription. These data 
clearly show that inhibition of methyltransferases renders the chromatin structure of 
lineage-restricted cells more susceptible to the reprogramming, therefore facilitating the re-
activation of the transcription of pluripotency factors. This concept was corroborated by 
another study where it was shown that treatment with histone deacetylase (HDAC) 
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inhibitors such as valproic acid, after transfection with four or only three reprogramming 
factors also improved the reprogramming efficiency (Huangfu et al., 2008a). In addition, the 
combination of HDAC inhibitor and the DNA methyltransferase inhibitor significantly 
enhanced the kinetics and efficiency of the reprogramming. Furthermore by using HDAC 
inhibitors it was possible to reprogram human fibroblasts transfecting the cells only with 
two factors (Oct3/4 and Sox2) instead of four (Huangfu et al., 2008b).  
In conclusion, despite having found the essential factors needed for reprogramming 
differentiated cells, still much has to be clarified before this technique can be used for 
therapeutical purposes. Reprogramming is a balanced interplay between epigenetic changes 
and re-activation or suppression of specific gene expression. Controlling these sophisticated 
processes will surely be the topic for future studies. Nevertheless the combined chemical 
and genetic approach seems to be nowadays a good combination for driving and facilitating 
this complicated but powerful process. Moreover a combined approach permits a more 
precise and time controlled manipulation of the reprogramming processes. 
7. Conclusions 
We aimed in this chapter at reviewing the current knowledge regarding maintenance of 
pluripotency in embryonic and induced pluripotent stem cells. Even though in the past 
years many different key factors could be identified, how they interact between each other 
and control the pluripotent cell identity is still largely unknown. Understanding these 
mechanisms is essential because ESCs and iPSCs hold great promise for the therapeutic 
treatment of human diseases. Successful reprogramming of differentiated cells into iPSCs 
needs faithful remodelling of epigenetic modifications, because epigenetic aberrations often 
induce pathological conditions such as cancer. Therefore a thorough understanding of the 
epigenetic remodelling involved in reprogramming somatic cells is of fundamental interest. 
The field of stem cell research is one of the great challenges of our times and in the next 
future extensive studies aimed at the clarification of the correlations between pluripotency 
and epigenetic will be necessary. The advent of the modern high throughput technologies 
will open new possibilities in understanding the mechanisms ruling cell fate. All this will 
lead to the discovery not only of new mechanisms and key players determining 
pluripotency, but also will allow expanding the knowledge how to drive controlled 
differentiation of pluripotent cells towards pure populations of precursors and terminally 
differentiated cells, by identifying the right signals and culture environments. 
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